Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Adavanced or Metastatic Renal Cells Cancer
Conditions: Renal Cell Carcinoma Metastatic; Renal Cell Carcinoma Stage IV; Renal Cell Carcinoma Stage III Interventions: Drug: Cabozantinib Sponsors: Fundacion Oncosur Terminated
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Research